Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker MAZE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 5,345 | $31.05 | $166.0K Sale | Form 4 ↗ |
| Nov 2, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 26,563 | $30.10 | $799.4K Sale | Form 4 ↗ |
| Nov 2, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 336 | $30.91 | $10.4K Sale | Form 4 ↗ |
| Nov 2, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 2,257 | $30.12 | $68.0K Sale | Form 4 ↗ |
| Oct 29, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 7,500 | $32.07 | $240.5K Sale | Form 4 ↗ |
| Sep 4, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 9,705 | $26.22 | $254.5K Sale | Form 4 ↗ |
| Sep 3, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 59 | $25.78 | $1,521 Sale | Form 4 ↗ |
| Sep 3, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 5,130 | $26.01 | $133.4K Sale | Form 4 ↗ |
| Sep 3, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 36 | $25.81 | $929 Sale | Form 4 ↗ |
| Sep 3, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 3,207 | $26.01 | $83.4K Sale | Form 4 ↗ |
| Sep 3, 2026 | Courtney Phillips GC and Corp. Secretary | MAZE Maze Therapeutics, Inc. | Sale | 22 | $25.78 | $567 Sale | Form 4 ↗ |
| Sep 3, 2026 | Courtney Phillips GC and Corp. Secretary | MAZE Maze Therapeutics, Inc. | Sale | 1,990 | $26.01 | $51.8K Sale | Form 4 ↗ |
| Sep 3, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 129 | $25.77 | $3,324 Sale | Form 4 ↗ |
| Sep 3, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 11,282 | $26.01 | $293.4K Sale | Form 4 ↗ |
| Sep 2, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 625 | $27.12 | $16.9K Sale | Form 4 ↗ |
| Sep 2, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 4,481 | $26.38 | $118.2K Sale | Form 4 ↗ |
| Sep 2, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 391 | $27.12 | $10.6K Sale | Form 4 ↗ |
| Sep 2, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 2,800 | $26.38 | $73.9K Sale | Form 4 ↗ |
| Sep 2, 2026 | Courtney Phillips GC and Corp. Secretary | MAZE Maze Therapeutics, Inc. | Sale | 243 | $27.12 | $6,590 Sale | Form 4 ↗ |
| Sep 2, 2026 | Courtney Phillips GC and Corp. Secretary | MAZE Maze Therapeutics, Inc. | Sale | 1,738 | $26.38 | $45.8K Sale | Form 4 ↗ |
| Sep 2, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 1,375 | $27.12 | $37.3K Sale | Form 4 ↗ |
| Sep 2, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 9,852 | $26.38 | $259.9K Sale | Form 4 ↗ |
| Sep 1, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 16,141 | $26.36 | $425.5K Sale | Form 4 ↗ |
| Sep 1, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 31,908 | $26.29 | $838.9K Sale | Form 4 ↗ |
| Sep 1, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 2,593 | $26.31 | $68.2K Sale | Form 4 ↗ |
| Aug 28, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 7,500 | $27.58 | $206.8K Sale | Form 4 ↗ |
| Aug 13, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 16,142 | $27.61 | $445.7K Sale | Form 4 ↗ |
| Aug 3, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 1,604 | $27.09 | $43.5K Sale | Form 4 ↗ |
| Aug 3, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 30,304 | $26.71 | $809.4K Sale | Form 4 ↗ |
| Aug 3, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 154 | $27.09 | $4,172 Sale | Form 4 ↗ |
| Aug 3, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 2,439 | $26.71 | $65.1K Sale | Form 4 ↗ |
| Jul 29, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 400 | $27.89 | $11.2K Sale | Form 4 ↗ |
| Jul 29, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 7,100 | $27.31 | $193.9K Sale | Form 4 ↗ |
| Jul 1, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 1,200 | $30.34 | $36.4K Sale | Form 4 ↗ |
| Jul 1, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 13,409 | $29.87 | $400.5K Sale | Form 4 ↗ |
| Jul 1, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 1,597 | $30.44 | $48.6K Sale | Form 4 ↗ |
| Jul 1, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 30,311 | $29.95 | $907.8K Sale | Form 4 ↗ |
| Jul 1, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 2,593 | $29.98 | $77.7K Sale | Form 4 ↗ |
| Jun 29, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 7,500 | $28.02 | $210.2K Sale | Form 4 ↗ |
| Jun 23, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 23,865 | $26.05 | $621.7K Sale | Form 4 ↗ |
| Jun 22, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 2,040 | $26.00 | $53.0K Sale | Form 4 ↗ |
| Jun 22, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 1,953 | $26.00 | $50.8K Sale | Form 4 ↗ |
| Jun 1, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 1,600 | $26.36 | $42.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Harold Bernstein President, R&D & CMO | MAZE Maze Therapeutics, Inc. | Sale | 13,253 | $25.57 | $338.9K Sale | Form 4 ↗ |
| Jun 1, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 553 | $26.24 | $14.5K Sale | Form 4 ↗ |
| Jun 1, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 6,090 | $26.20 | $159.6K Sale | Form 4 ↗ |
| May 29, 2026 | Atul Dandekar CSBO | MAZE Maze Therapeutics, Inc. | Sale | 7,500 | $26.34 | $197.6K Sale | Form 4 ↗ |
| May 26, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 25,582 | $26.02 | $665.6K Sale | Form 4 ↗ |
| May 22, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 2,478 | $26.00 | $64.4K Sale | Form 4 ↗ |
| May 22, 2026 | Jason V. Coloma Chief Executive Officer, Director | MAZE Maze Therapeutics, Inc. | Sale | 4,504 | $26.00 | $117.1K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:21 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances